THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner

THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner

Glioblastoma (GBM) is the most frequent malignant tumor of the central nervous system in humans with a median survival time of less than 15 months. ∆<sup>9</sup>-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best-characterized components of <i>Cannabis sativa</i> p...

Full description

Bibliographic Details
Main Authors: Marc Richard Kolbe, Tim Hohmann, Urszula Hohmann, Chalid Ghadban, Ken Mackie, Christin Zöller, Julian Prell, Jörg Illert, Christian Strauss, Faramarz Dehghani
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
brain tumor
glioblastoma
THC
CBD
cannabidiol
CB<sub>1</sub>
Online Access:https://www.mdpi.com/2072-6694/13/5/1064

Similar Items

Similar Items